A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms
Paru S David,1 Taryn L Smith,2 Hannah C Nordhues,3 Juliana M Kling1 1Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA; 2Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA; 3Department of Internal Medicine, Mayo Clinic, Rochester, MN, USACorrespondence: Paru S David,...
Saved in:
Main Authors: | David PS (Author), Smith TL (Author), Nordhues HC (Author), Kling JM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical appraisal of paroxetine for the treatment of vasomotor symptoms
by: Carroll DG, et al.
Published: (2015) -
Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
by: Khan SJ, et al.
Published: (2023) -
Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
by: Uml, et al.
Published: (2012) -
The efficacy and safety of genistein in the treatment of vasomotor symptoms in postmenopausal women (research review)
by: I V Kuznetsova
Published: (2013) -
Breakthroughs in women's health for treating vasomotor symptoms
by: Peng-Hui Wang, et al.
Published: (2024)